Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > phase one

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Mar 31, 2022 5:06pm

134 Views

Post# 34564669

RE:RE:RE:RE:phase one

How about I give you %100 percecnt of what I made for pumping the stock? Would that be fair?

I don't need to disclaim anything, if you guys don't see a penny stock as a high risk you shouldn't be investing.

No one cheating you into buying anything you listened to what they said calculated the risk and bought. All of us are where we are by choice, and some by greed.

I expect to lose warrants but do quite well on the stock I hold so its an insignificant loss. If you didn't buy stock are a sitting with only warrarnts than thats a bad loss for you.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario